Month: April 2022

FORT STOCKTON, TEXAS, April 28, 2022 (GLOBE NEWSWIRE) — Today, the Province of Tierra del Fuego and MMEX jointly announce the potential development of a green hydrogen project in the Río Grande area.

The Governor of the Province of Tierra del Fuego, Mr. Gustavo Adrian Melella, announced that, “MMEX, a North American company with operations in Texas USA with extensive experience in the implementation, financing and operation of energy infrastructure in Latin America and the USA, is evaluating a project for the production of 55 tons of green hydrogen with 160 megawatts of base wind power.”

Governor Melella added, “The excellent wind conditions in the Río Grande area, which allow efficient logistics and production and direct access to the sea, are the basis for MMEX’s entry into Argentine Patagonia. The final objective would be the implementation of a green hydrogen node destined to export to Europe and Asia. We welcome and support the participation of MMEX in Tierra del Fuego.”

Jack W. Hanks, the CEO of MMEX stated, “We are very excited to join the Government of Tierra del Fuego to plan this project. The global focus on renewable energy and the need to reduce the planet’s carbon footprint is at the core of Tierra del Fuego and MMEX’s strategy, drawing on MMEX’s green hydrogen expertise.”

Hanks added, “Since 1989, in Texas and Peru, MMEX has built and operated thermoelectric plants, oil and gas pipelines, oil refineries and ethanol plants. It has also explored and operated oil and gas fields. MMEX, in conjunction with Siemens Energy, recently completed a front-end engineering design study for the production of 55 tons per day of hydrogen for this project and its other projects in Texas. Hydrogen can be transformed into Ammonia or Methanol for global exports. It is estimated that the investment will be in the range of US $500 million, generating up to 1,500 jobs in the construction stage and 300 qualified and permanent jobs in the operation stage.”

Hanks further commented, “Siemens Energy is a leading manufacturer of electrolysis equipment that enables the transition to clean energy. MMEX has also signed a memorandum of understanding with Siemens Energy and Siemens Gamesa, one of the world leaders in the production of wind towers, which is associated with the realization of this project. This will allow defining the necessary wind turbine and the required land to implement a 160MW wind farm that supplies electrical energy to the Siemens electrolysers to produce hydrogen.”

Governor Melella added, “The province of Tierra del Fuego and MMEX have signed agreements on the exchange of technical information. This allows rapid progress in the preliminary assessment of wind potential.”

The provincial government, within its support for the development of renewable energy industries, welcomes initiatives that allow the sustainable use of Tierra del Fuego’s resources and reaffirms, as a government, its commitment to sustainable development, the preservation of the environment, investment and employment.

The following constitutes a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties, which could cause our actual results to differ materially from those described in the forward looking statements. These risks include but are not limited to the Company’s ability to continue as a going concern, our lack of revenues, general business conditions, the requirement to obtain significant financing to pursue our business plan, our history of operating losses and other risks detailed from time to time in the Company’s SEC reports. In particular, readers should note MMEX undertakes no obligation to update forward-looking statements.

Kristen Quinn
MMEX Resources Corporation
kristen@paigepr.com

April 28, 2022

South Carolina’s largest health system adopts Philips software solutions for patient monitoring and enterprise imaging, helping to drive interoperability and data analytics, and deliver on Quadruple Aim

Amsterdam, the Netherlands and South Carolina, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Prisma Health, South Carolina’s largest non-profit healthcare system, today announced they have entered into a multi-year agreement to help the health system achieve enterprise interoperability, standardize patient monitoring, and drive innovation in enterprise imaging solutions to enhance patient care and improve clinical performance. As South Carolina’s largest private, non-profit healthcare system, and second-largest private company, Prisma Health wants to deliver on the quadruple aim: improve patient and staff satisfaction, lower costs, and improve outcomes for all South Carolinians.

Prisma Health was formed in 2017 when Greenville Health System and Palmetto Health, two of South Carolina’s most highly regarded healthcare systems, came together as one organization. Today, Prisma Health has nearly 3,000 licensed beds and 18 acute care and specialty hospitals, as well as 270 physician practices servicing 21 counties. They treat over one million unique patients across their networks each year, including 368,000 virtual care visits, and just under half a million emergency department visits.

“When our two regional healthcare organizations merged, an enterprise-wide technology strategy became critical to standardize best practices across the whole system, creating new bridges between hospital and home care and continuing to drive innovation,” said Rich Rogers, Senior Vice President, Chief Information Officer, Prisma Health.  “At Prisma Health, we wanted to engage a partner to help us address data integration and unlock the power of patient data so that we are able to provide our patients with the best care anywhere in our service areas. We want to put the right tools into the hands of our clinicians to allow them to better share information, collaborate and help transform care for the communities we serve.”

With the Philips HealthSuite secure cloud platform at its foundation, Philips is committed to enterprise interoperability. Philips’ solutions portfolio includes real-time patient monitoring, therapeutic devices, telehealth, image management and informatics solutions including radiology and cardiology PACS, advanced visualization, vendor neutral archive (VNA) and Philips Enterprise Viewer – Vue Motion, and interoperability solutions, including the industry-leading Philips Capsule Medical Device Information Platform. Prisma Health will not only have access to these technologies, they will also be the largest installation of the Philips Enterprise Performance Analytics – Performance Bridge – analytics platform in North America. Performance Bridge gives healthcare professionals access to near real-time data on departmental performance through an easy-to-use interactive dashboard. Vendor agnostic, Performance Bridge unifies information across different imaging modalities and informatics solutions to optimize organizational efficiency, drive adherence to standards of care and facilitates additional revenue streams. Prisma Health plans to use Performance Bridge to drive innovation and monitor their delivery of quality healthcare.

“At Philips, we made a deliberate decision to create an end-to-end enterprise strategy that will help our customers overcome interoperability barriers and enable data sharing,” said Vitor Rocha, Chief Market Leader for Philips North America. “Health systems shouldn’t have to worry about integrating technology, which is why we have developed vendor-agnostic solutions based on standards and frameworks that bring together data from applications, systems, and devices. This allows our partners to focus on what is most important to them and their patients – continuously improving the patient journey and outcomes.”

Long-term strategic partnerships (LSPs) are a growing trend within hospitals and health systems to better manage the cost and complexity of their technology investments over a defined period of time, while expanding quality access to advanced medical care to improve patient outcomes. Philips is a leader in LSPs and continues to work with forward-thinking organizations like Prisma Health to develop standards, best practices, and predictive technologies that can redefine the future of healthcare.

For further information, please contact:

Mark Groves
Philips Global Press Office
Tel.: +31 631 639 916
E-mail: mark.groves@philips.com

Silvie Casanova
Philips North America
Tel.: +1 781 879 0692
E-mail: silvie.casanova@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About Prisma Health
Prisma Health is a non-profit health company and the largest healthcare system in South Carolina. With nearly 30,000 team members, 18 acute and specialty hospitals, 2,947 beds and more than 300 outpatient sites with nearly 2,000 physicians, Prisma Health serves more than 1.5 million unique patients annually in its 21-county market area that covers 50% of South Carolina. Prisma Health’s goal is to improve the health of all South Carolinians by enhancing clinical quality, the patient experience and access to affordable care, as well as conducting clinical research and training the next generation of medical professionals. Visit PrismaHealth.org for more information.

Attachment

• Doctor showing images on Philips Enterprise Viewer

Enterprise-grade cloud security and data privacy gives FourKites customers and partners additional peace of mind

CHICAGO, April 28, 2022 (GLOBE NEWSWIRE) — Leading real-time supply chain visibility platform FourKites^® today announced it meets the standards set by the International Standards Organization (ISO) for ISO 27017 for cloud service security and ISO 27018 for data privacy as part of its ISO 27001 certification. The achievement represents FourKites’ ongoing pursuit of the most recent and stringent security standards in the industry.

To qualify, an independent audit committee confirmed that FourKites meets a stringent set of requirements around security and privacy. ISO 27017 provides guidelines for information security controls applicable to and specific to the provisioning and use of cloud services, while ISO 27018 establishes commonly accepted controls and guidelines for implementing measures to protect personally identifiable information (PII) for the public cloud computing environment. Meanwhile, ISO 27001 mandates controls for the establishment, maintenance and certification of an information security management system (ISMS).

“Meeting these standards is a testament to FourKites’ ongoing commitment to go above and beyond when it comes to securing our platform, which ingests more than 250 terabytes of data each month,” said Mathew Elenjickal, FourKites Founder and CEO. “Safe and secure data sharing has tremendous benefits across the supply chain, including more accurate business planning and risk mitigation, higher customer satisfaction and retention, and improved employee morale.”

Adherence to ISO 27017 and 27018 is the latest validation of FourKites’ rigorous security efforts, including its comprehensive General Data Protection Regulation (GDPR) privacy program, which even applies in regions where it is not required and incorporates the Schrems II ruling.

“Our supply chain customers and partners around the globe can rest assured that FourKites uses the strongest and most secure standards in the industry to protect their valuable data,” added Elenjickal.

FourKites delivers real-time insights to customers around the globe, leveraging patented artificial intelligence based on 150 factors, including ​​weather, traffic and real-time data from GPS, ELD telematics networks, mobile devices, AIS and more. The company offers out-of-the-box dashboards and reports, automated and customizable notifications that leverage geofencing and temperature tracking, and SKU-level visibility to track multimodal shipments, even when they’re split across multiple carriers.

In Spring 2021, FourKites was awarded a patent for its groundbreaking Smart Forecasted Arrival (SFA) solution, which provides companies with highly frequent and accurate estimated times of arrival for over-the-road freight in transit — even when a truck lacks any technology to transmit location data. SFA is now available to FourKites customers globally, extending the benefits of real-time visibility to freight that would otherwise be invisible to modern supply chain management solutions.

About FourKites
FourKites^® is the #1 global supply chain visibility platform, extending visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.5 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching more than 185 countries, FourKites combines real-time data and powerful machine learning to help companies digitize their end-to-end supply chains. More than 1,000 of the world’s most recognized brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.

Media Contacts
Marianna Vyridi
Big Valley Marketing for FourKites
(650) 468-3263
mvyridi@bigvalley.co

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5ed752ac-3bf9-4eaf-bb8b-e08ba31b326d

Copyright © 2022 GlobeNewswire, Inc.

Hong Kong to be gateway for CMR Surgical in APAC region

• CMR Surgical to expand commercial roll out in world leading surgical robotic market
• Leading teaching hospitals in Hong Kong – CUHK Medical Centre and Gleneagles Hospital – have introduced Versius

Cambridge, United Kingdom. 28 April 2022 00:01 (GMT). CMR Surgical – the global surgical robotics business – has today announced the introduction of the Versius^® Surgical Robotic System in Hong Kong at CUHK Medical Centre (CUHKMC) and Gleneagles Hospital Hong Kong (GHK). CUHKMC was the first hospital in Hong Kong to introduce Versius where it is being used as part of a multidisciplinary robotic programme, including general surgery and urology. At Gleneagles, Versius has been used first in gynaecologic surgery, with plans to expand into general surgery and others as part of a multispecialty programme.

With Versius, both CUHKMC and GHK are offering robotic assisted surgery directly to patients through state-of-the-art specialty centres, bringing accessible surgical care to more patients. With one of the longest life expectancies in the world, Hong Kong’s healthcare sector is a global leader in utilising high tech equipment and surgical solutions for patients, presenting a significant opportunity for Versius to be widely adopted in private and public hospitals. APAC will be a major growth engine for surgical robotics where rapid digitalisation, rising demand and access to healthcare innovation will drive further adoption of health technology and innovations like Versius.

Per Vegard Nerseth, Chief Executive Officer of CMR Surgical said: “We have eagerly awaited our launch in Hong Kong to offer the city’s world leading healthcare system access to pioneering new technology, I am thrilled that we have entered such a robust and innovative market. Hong Kong will be our springboard to the rest of APAC as we prepare for further developments in the region in due course and continue to set CMR Surgical on the global stage.”

Dr Patrick Lau, Deputy Executive Director of the Hong Kong Trade Development Council commented: “Hong Kong is a leader in embracing innovation and technology, including in Healthcare. A novel robotic system such as Versius that will positively impact patients fits perfectly into this mould. We are delighted that CMR has chosen Hong Kong as the launchpad for the Asia Pacific region as we believe that Hong Kong offers biotechnology companies an ideal springboard from which to expand into rapidly growing markets in Mainland China, Asia and around the world.”

While the benefits of keyhole surgery for patients such as shorter recovery time, less pain and a lower risk of surgical site infections are well recognised, traditional manual keyhole surgery can be difficult to perform, leading many complex procedures to be performed via open surgery.ⁱ Surgical robotic systems such as Versius provide increased accuracy, precision and dexterity for surgeons, allowing for more surgical procedures to be more easily performed through keyhole surgery. The size, portability and versatility of Versius has made it popular with hospitals and surgeons around the world and has made Versius a cornerstone in enabling more keyhole surgery.

Kin Cheung, Head of Far East of CMR Surgical said: “The impact of the pandemic has been felt across healthcare systems globally, and Hong Kong is no exception to this. With Hong Kong’s can-do spirit as their guide, hospitals are looking for innovative solutions that help to address this strain while providing accessible technology options to their patients. We are delighted to be partnering with leading hospitals, CUHK Medical Centre and Gleneagles Hospital Hong Kong, to expand the benefits of robotic keyhole surgery. It is great to see Versius standing out in Hong Kong and offering world leading surgeons a very different surgical robotic option. CMR will continue to expand our presence in Hong Kong in order to fulfil our customers’ growing demand.”

CMR has designed an agile commercial and pricing model to suit all global markets, increasing access for many people to minimal access (keyhole) surgery. The value of innovation Versius offers as a leading-edge robotic technology, fits well within an innovative and diverse healthcare ecosystem like Hong Kong’s and other markets in the APAC region.

To further invest into the market, CMR has partnered with leading training centre, the CUHK Jockey Club Minimally Invasive Surgical Skills Centre (Jockey Club MISSC), located within the Prince of Wales Hospital, to deliver training and professional education to surgical teams. The introduction of Versius in Hong Kong follows CMR Surgical’s expansion into a number of markets across Europe, Middle East, India and Australia where the system is being used to perform surgical procedures across a range of surgical specialities including gynaecology, colorectal surgery, thoracic, general surgery and urology.

— ENDS —

Media Contacts:

If you wish to see more, please contact CMR Surgical at:

Press Office, CMR Surgical
T +44(0) 1223 755801
E pressoffice@cmrsurgical.com

Notes to editors:

The Versius^® Surgical Robotic System

Versius^® resets expectations of robotic surgery. Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS). The small, portable and modular design of Versius allows the surgeon to only use the number of arms needed for a given procedure.

Biomimicking the human arm, Versius gives surgeons the choice of optimised port placement alongside the dexterity and accuracy of small fully-wristed instruments. With 3D HD vision, easy-to adopt instrument control and a choice of ergonomic working positions, the open surgeon console has the potential to reduce stress and fatigue and allows for clear communication with the surgical team. By thinking laparoscopically and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value that robotic MAS brings.

But it’s more than just a robot. Versius captures meaningful data with its wider digital ecosystem to support a surgeon’s continuous learning. Through the Versius Connect app, Versius Trainer and CMR clinical registry, Versius unleashes a wealth of insights to ultimately improve surgical care.

About CMR Surgical Limited

CMR Surgical (CMR) is a global medical devices company dedicated to transforming surgery with Versius^®, a next-generation surgical robot.

Headquartered in Cambridge, United Kingdom, CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make robotic minimal access surgery universally accessible and affordable. With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.

Founded in 2014, CMR Surgical is a private limited company backed by an international shareholder base.

ⁱ EUR Urol, Journal of Endourology, BMJ